A malignant extramedullary tumour made up of immature myeloid cells is known as a myeloid sarcoma (MS). It might develop from nothing and happen before, during, or after acute myeloid leukaemia (AML), or it can be the solitary sign of recurrent AML, myelodysplastic syndrome, or chronic myeloid leukaemia. Frequently afflicted organs include the testis, skin, orbit, bone, periosteum, lymph nodes, gastrointestinal tract, soft tissue, and central nervous system. Because of its many symptoms, localization, and absence of a diagnostic methodology, MS is challenging to diagnose. This is particularly valid for people whose initial bone marrow involvement is absent. For the best possible therapy of MS, a clear diagnosis is essential. which, since there is a considerable risk of misdiagnosis, is routinely postponed. We provided a review of the literature, three examples of MS originating from the spine, each with back pain, paraplegia, and paraparesis. To fully comprehend the peculiarities of isolated MS and to develop innovative and focused therapies, a bigger patient population in a global trial is required.
Shah Kajal,
Department of Medical Oncology and pediatric oncology, Gujarat Cancer Research, Institute, Ahmedabad, Gujarat, India.
Panchal Harsha,
Department of Medical Oncology and pediatric oncology, Gujarat Cancer Research, Institute, Ahmedabad, Gujarat, India.
Patel Apurva,
Department of Medical Oncology and pediatric oncology, Gujarat Cancer Research, Institute, Ahmedabad, Gujarat, India.
. Chinmay,
Department of Medical Oncology and pediatric oncology, Gujarat Cancer Research, Institute, Ahmedabad, Gujarat, India.
Parikh Sonia,
Department of Medical Oncology and pediatric oncology, Gujarat Cancer Research, Institute, Ahmedabad, Gujarat, India.
Please see the link here: https://stm.bookpi.org/CODHR-V1/article/view/7422
No comments:
Post a Comment